Drawing for AMICULUM

USPTO serial 79343199

AMICULUM

Reviewed by CopyMark Law Group

Reg. 7147516Status 700Registered
Filing date
Status date
Registration date
Aug 29, 2023
Examiner
BENMAMAN, ALICE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AMICULUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard M. LaBarge

Richard M. LaBarge Marshall, Gerstein & Borun LLP233 S. Wacker DriveSuite 6300Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
035Advertising, promotional and marketing services; business advice and consultancy services; business auditing; market research services; market studies; collection of health/medical/pharmaceutical/genetic/biological data for network of businesses in the medical, pharmaceutical/healthcare fields; data processing services; business management; procurement, namely, purchasing information technology, data security, and human resources services for others; business finance procurement services; business administration services; personnel recruitment; human resources management; employment recruitment servicesACTIVE—
041Provision of education and training in the field of health, medicine, genetics, disease, pharmacology, biotechnology, and pharmaceuticals; arranging and conducting courses, seminars, conferences, symposia, training workshops, colloquiums, exhibitions and congresses in the fields of health, medicine, genetics, disease, pharmacology, biotechnology, and pharmaceuticals; business training consultancy services; providing online non-downloadable electronic publications in the nature of books, newsletters, newssheets, textbooks, periodicals, journals, medical texts, magazines and brochures in the field of health, medicine, genetics, disease, pharmacology, biotechnology and pharmaceuticalsACTIVE—
042Scientific and technological services, namely, scientific research, analysis, testing, genetic fingerprinting, evaluation in the field of health, medicine, genetics, disease, pharmacology, biotechnology and pharmaceuticals; genetic testing for scientific research purposes; structural and functional analysis of genomes; genetic fingerprinting in the nature of genetic mapping for scientific and medical purposes; pharmaceutical product evaluation; medical and scientific research, namely, conducting clinical trials for others; preparation of technical or scientific reports in the field of health, medicine, genetics, disease, pharmacology, biotechnology and pharmaceuticals; development of computer software relating to the aforesaid services; commissioned writing, design, and development for others of computer programmes, computer software, and computer code for the creation of web pages on the Internet relating to health, medicine, genetics, disease, pharmacology, biotechnology, and pharmaceuticals; commissioned writing of computer programmes, software, and code for others for the creation of web pages on the Internet; electronic data storage; information, consultancy, and advice relating to all the aforesaid servicesACTIVE—
044Medical services; managed health care services; home health care services; genetic testing for medical purposes; medical diagnostic testing services; medical screening services in the field of health, medicines, genetics, diseases, pharmacology, biotechnology, and pharmaceuticals; pharmaceutical advice; information, advice, and consultancy in the medical, pharmaceutical and healthcare sectorsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 26, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 4, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 4, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 29, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 29, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 29, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 13, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 13, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 13, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 24, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 24, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 24, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 28, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 5, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 5, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 5, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 20, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 28, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 27, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 27, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 25, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 24, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2022DOCKASSIGNED TO EXAMINER—
Jun 24, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 23, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance